* Artemisinin resistance have been documented in Myanmar and Myanmar artemisinin resistance containment measures have been launched since 2009-2010. * It is important to monitor the spread and magnitude of artemisinin resistant malaria in Myanmar. * So, day-3 surveillance study have been conducted. * Recently artemisinin resistant molecular marker, K13 have been identified and it was used as a tool in this study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
day-3 parasite positivity
Timeframe: 3 days